Table 2. Characteristics of COVID-19+ patients according to clinical outcome.

Characteristic	COVID-19+ (Alive)	COVID-19+ (Dead)	P
Number	172	34
Age	76 (62–85)	87 (80–89)	<0.001
Female Sex	96 (55.8%)	17 (50.0%)	0.53
Black	56 (32.6%)	6 (17.6%)	0.21
White	95 (55.2%)	24 (70.6%)
BMI	28.67 (23.65–35.17)	28.235 (24.64–33.21)	0.98
HFrEF	33 (19.2%)	3 (8.8%)	0.15
Hypertension	138 (80.2%)	26 (76.5%)	0.62
COPD	55 (32.0%)	12 (35.3%)	0.71
CAD	55 (32.0%)	18 (52.9%)	0.02
Kidney Disease	60 (34.9%)	19 (55.9%)	0.02
NT-proBNP	1289 (435–4016)	4275 (1090–7351)	0.03
Sodium	139 (137–142)	139 (135–142)	0.48
Chloride	102 (99–106)	102 (96–106)	0.8
Creatinine	1.2 (0.9–1.8)	1.7 (1.3–2.9)	<0.01
BUN	27.5 (18–45)	37 (25–48)	0.03
HbA1c	6.5 (5.7–7.6)	6.4 (5.9–8.1)	0.73
ACE-I/ARB	51 (29.7%)	7 (20.6%)	0.28
Beta Blocker	72 (41.9%)	22 (64.7%)	0.015
LDH	298 (242–408)	373 (268–419)	0.05
Troponin T	0.02 (0–0.05)	0.06 (0.02–0.13)	<0.001
Procalcitonin	0.16 (0.08–0.41)	0.37 (0.16–1.13)	0.004
INR	1.05 (0.99–1.18)	1.13 (1.03–1.42)	0.04
Fibrinogen	500 (383–597)	480 (371–611)	0.95
Ferritin	501 (186–876)	694 (233–1524)	0.05
D-dimer	1.25 (0.73–2.44)	1.19 (0.75–3.30)	0.40
CRP	50 (13–119)	85 (24–213)	0.05
AST	34 (22–50)	43 (30–87)	0.01
ALC	0.9 (0.6–1.3)	0.6 (0.4–0.9)	<0.01

Data are presented as median (IQR) for continuous measures, and n (%) for categorical measures.